PubMed=2985508; DOI=10.1002/ijc.2910350404
Rowe M., Rooney C.M., Rickinson A.B., Lenoir G.M., Rupani H., Moss D.J., Stein H., Epstein M.A.
Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma.
Int. J. Cancer 35:435-441(1985)

PubMed=2824665; DOI=10.1099/0022-1317-68-11-2853
Young L.S., Yao Q.Y., Rooney C.M., Sculley T.B., Moss D.J., Rupani H., Laux G., Bornkamm G.-W., Rickinson A.B.
New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
J. Gen. Virol. 68:2853-2862(1987)

PubMed=3037521; DOI=10.1073/pnas.84.13.4567
Masucci M.G., Torsteinsdottir S., Colombani J., Brautbar C., Klein E., Klein G.
Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
Proc. Natl. Acad. Sci. U.S.A. 84:4567-4571(1987)

PubMed=2898508; DOI=10.1084/jem.167.6.1811
Gregory C.D., Murray R.J., Edwards C.F., Rickinson A.B.
Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.
J. Exp. Med. 167:1811-1824(1988)

PubMed=7601573; DOI=10.1002/ijc.2910620117
Imreh M.P., Zhang Q.-J., de Campos-Lima P.O., Imreh S., Krausa P., Browning M.J., Klein G., Masucci M.G.
Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma.
Int. J. Cancer 62:90-96(1995)

PubMed=9473234; DOI=10.1182/blood.V91.5.1680
Klangby U., Okan I., Magnusson K.P., Wendland M., Lind P., Wiman K.G.
p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma.
Blood 91:1680-1687(1998)